Inhibition by endotoxemia of rat liver regeneration following partial hepatectomy with special reference to cytokine production

Hepatology Research

Volumn 13, Issue 2, 1999, Pages 120-132

  Morii, Yuji ^a   Kawano, Katsunori ^a   Hiratsuka, Koichi ^a   Inomata, Masafumi ^a   Yoshida, Takanori ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

70 Hepatectomy; Endotoxin; HGF; TGF 1

Indexed keywords

CYTOKINE; ENDOTOXIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENDOTOXEMIA; ENZYME INDUCTION; GROWTH INHIBITION; LABELING INDEX; LIVER INJURY; LIVER ISCHEMIA; LIVER REGENERATION; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION;

EID: 0032962170     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00084-9     Document Type: Article

References (25)

1. Kawano K., Kim Y.I., Kai T.et al. Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: in vivo demonstration for suppression of TNF-α production in response to endotoxemia. Eur Surg Res. 26:1994;108-115.
2. Hewitt G., Halliday I., McCaigue M., Campbell G., Rowlands B., Diamond T. Mortality, endotoxemia and cytokine expression after intermittent and continuous hepatic ischemia. Br J Surg. 82:1995;1424-1426.
3. Tarao K., So K., Moroi T.et al. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterology. 73:1977;539-542.
4. Thompson J.N., Cohen J., Moore R.H.et al. Endotoxemia in obstructive jaundice. Observations on cause and clinical significance. Am J Surg. 155:1988;314-321.
5. Tsukamoto I., Nakata R., Kojo S. Effect of endotoxin on rat liver regeneration after partial hepatectomy. Biochem Int. 27:1992;1047-1050.
6. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 16:1984;1450-1459.
7. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA. 83:1986;6489-6493.
8. Nakamura T., Tomita Y., Hirai R., Yamaoka K., Kaji K., Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun. 133:1985;1042-1050.
9. Russell W.E., Coffey R. Jr., Ouellette A.J., Moses H.L. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 85:1988;5126-5130.
10. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol. 6:1990;597-641.
11. Jakowlew S.B., Mead J.E., Danielpour D., Wu J., Roberts A.B., Fausto N. Transforming growth factor-β (TGF-β) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-β Cell Regul. 2:1991;535-548.
12. Matsumoto K., Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. Experientia. 65:1993;225-249.
13. Zarnegar R., DeFrances M.C., Kost D.P., Lindroos P., Michalopoulos G.K. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun. 177:1991;559-565.
14. Braun L., Mead J.E., Panziea M., Mikumo R., Bell G.I., Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA. 85:1988;1539-1543.
15. Masuhara M. Expression of hepatocyte growth factor and transforming growth factor β1 mRNA in P. acnes and lipopolysaccharide-treated rats. J Gastroenterol. 30:1995;48-54.
16. Higgins G.M., Anderson R.M. Experimental pathology of the liver. Arch Pathol. 12:1931;186-202.
17. Cohn I. The toxic factor in closed loop obstruction. Am J Surg. 104:1962;482-489.
18. Nordstoga K., Aasen A.O. Hepatic changes in late canine endotoxin shock. A light and electron microscopic investigation. Acta Pathol Microbiol Scand. 87:1979;335-346.
19. Hirata K., Kaneko A., Ogawa K., Hayasaka H., Onoe T. Effect of endotoxin on rat liver. Analysis of acid phosphatase isozymes in the liver of normal and endotoxin treated rats. Lab Invest. 43:1980;165-171.
20. Shibayama Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol. 151:1987;315-321.
21. Mochida S., Ogata I., Hirata K., Ohta Y., Yamada S., Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology. 99:1990;771-777.
22. Maeda T., Ohnishi H., Hayashi T., Ishiki Y., Moriwaki H., Muto Y. Treatment with a novel lipid A analogue, FS-112, and partial hepatectomy causes submassive liver necrosis and impaired liver regeneration in mice. J Gastroenterol Hepatol. 11:1996;471-477.
23. Yanagita K., Nagaike M., Ishibashi H., Niho Y., Matsumoto K., Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 182:1992;802-809.
24. Noji S., Tashiro K., Koyama E.et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun. 173:1990;42-47.
25. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem. 267:1992;24917-24920.